Drawing for WOUNDZINC

USPTO serial 87921044

WOUNDZINC

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
CORWIN, KEVIN SCOTT
Law office
TMO LAW OFFICE 112 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with WOUNDZINC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Hope V. Shovein

Hope V. Shovein Brooks Kushman, P.C.1000 Town Center, 22nd FloorSouthfield, MI 48075UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Antiseptic liquid bandages; Antiseptic preparations; Antiseptics; Chemical preparations for sanitary purposes; Chemical preparations for sanitary use; Chemical reagents for medical or veterinary purposes; Dressings for wounds, ulcers, lacerations, incisions, abscesses; Pharmaceutical agents for epidermis; Pharmaceutical agents for treating physically caused lesions; Pharmaceutical preparation for skin care; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the treatment and prevention of wounds, ulcers, lacerations, incisions, abscesses; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of wounds, ulcers, lacerations, incisions, abscesses; Pharmaceutical preparations for treating dandruff; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for wounds; Pharmaceutical preparations for wounds, ulcers, lacerations, incisions, abscesses; Pharmaceutical preparations, namely, antivirals; Pharmaceutical products for skin care for animals; Pharmaceuticals, namely, anti-infectives; Pharmaceuticals, namely, antihelmintics; Antibacterial pharmaceuticals; Bandages for dressings; Bandages impregnated with pharmaceutical preparations in the nature of activated zinc for the treatment of wounds, ulcers, surgical incisions, and abscesses; Burn dressings; Chemical preparations for pharmaceutical or medical purposes, namely, for wounds, ulcers, lacerations, incisions, abscesses; Dermatological pharmaceutical products; Disinfectants for chemical toilets; Disposable wipes impregnated with disinfecting chemicals or compounds therefor for use in hospitals, clinics, operating rooms, nursing homes; Gauze for dressings; Intravenous bags sold filled with pharmaceutical preparations in the nature of activated zinc solutions for the treatment of wounds, ulcers, surgical incisions, and abscesses; Medical dressings; Medical and surgical dressings; Sponges impregnated with antiseptics; Sterilized dressing; Surgical dressings; Syringes sold filled with pharmaceutical preparations in the nature of activated zinc solutions for the treatment of wounds, ulcers, surgical incisions, and abscesses; Veterinary pharmaceutical preparations for the prevention of wounds, ulcers, lacerations, incisions, abscesses; Veterinary pharmaceutical preparations for the treatment of wounds, ulcers, lacerations, incisions, abscesses; Wound dressings; all of the aforementioned goods containing zincACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Nov 13, 2019MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Nov 13, 2019ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Apr 30, 2019GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Apr 30, 2019GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 30, 2019CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 19, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 18, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 18, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 17, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 17, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 17, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 5, 2018DOCKASSIGNED TO EXAMINER—
May 22, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 18, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance